BioSpace News Archive

Nykode Therapeutics ASA (OSE: NYKD) today announced it will report its financial results for the third quarter of 2022 on November 23, 2022 before market open and subsequently host a webcast presentation at 4 p.m. CET / 10 a.m. ET.

International Isotopes Inc. announces its financial results for the three and nine months ended September 30, 2022.

The global Therapeutic Drug Monitoring market valued at USD 1,453.7 Million in 2020 and is expected to reach USD 2,429.1 Million by year 2030, at a CAGR of 6.6%.

The global ELISpot and Fluorospot Assay market was valued at USD 123.5 million in 2018 and is expected to reach USD 408.8 million by the year 2030, at a CAGR of 15.9%.

Precision ADM, a leading Canadian additive manufacturer, is announcing the formation of a strategic partnership with Tecomet, a global leader in the design, development, and manufacturing of components for the medical, aerospace and defence industries.

Flexible, wearable electronics are making their way into everyday use, and their full potential is still to be realized.

Quadrant Biosciences announced today that the U.S. Patent and Trademark Office (USPTO) has awarded the company and two of its academic partners, the State University of New York Research Foundation and the Penn State Research Foundation, with U.S. Patent No.11,453,914 for the analysis and prediction of mild traumatic brain injury (mTBI) and concussion symptoms.

According to Nova one advisor, the global Antibody Drugs market was valued at USD 560.7 million in 2021 and it is expected to hit around USD 1.2 billion by 2030 with a CAGR of 4.8% during the forecast period 2022 to 2030.

Anivive Lifesciences, a technology-driven pet pharmaceutical company currently in late-stage development on the commercialization of a Canine Valley Fever Vaccine, announces they will be co-sponsoring The National Academies of Sciences, Engineering, and Medicine - Impact and Control of Valley Fever workshop.

Today at the CES Unveiled New York event, Radius XR™, a new fashion-forward wearable healthcare technology brand, was named a CES® 2023 Innovation Awards Honoree in both the Digital Health and Virtual & Augmented Reality categories.